IBIO, ARNA, & Today’s Extended Watchlist

iBio, Inc. IBIO

We’ve been quietly watching IBIO for quite some time. This AMEX stock has been on a consistant downtrend for the past couple of months, and is reaching the point where we felt it was time to begin sniffing for a bottom.

As you can see from the chart below, IBIO has the look of a stock that could be in for quite a recovering run once that ultimate bottom is reached. Shares from this price level could really turn out to be a bargain in the long run.

_____

Arena Pharmaceuticals, Inc. ARNA

ARNA hit a high of 8.65 on Wednesday.  That’s a 57% gain from the stock’s low (5.50) following our initial alert. It appears that many investors are, like us, highly anticpating the possibility of ARNA’s FDA Approval.

We’ve already seen sizable gains from ARNA, and certainly would like to keep the stock on our radars for the forseeable future. We will, of course, keep you updated as to the situation.

____

We’d like to congratulate any traders who managed to trade RGIN successfully yesterday, as it was not for the faint of heart. The stock opened at .285 yesterday, and hit a high of .44 before falling into the close at .20. Savvy traders could still have made an intraday gain of 54% early on, and if anyone caught the afternoon bounce from .151 to .249 that came following the high of day, an additional 62% gain was possible.

____

Extended Watchlist:
JASO, VPER, THWI, OMVE

THWI, OMVE & Today’s Extended Watchlist

Thwapr, Inc. THWI

Within the past month, THWI has exploded 1336% from .0055 to .079. The stock ran into resistance at the 200DMA. After such a surge, consolidation, which we’ve been seeing over the past couple of weeks, is to be expected.

THWI has been maintaining support above the 20DMA, and has made higher lows for the past five sessions. To us, that seems like a recipe for another possible breakout.

Apart from a nice chart setup, the company has had a slew of PR’s over the past few weeks that we’ve linked to below. We’ve also included a video chart for your convenience.

Recent Press:

Thwapr Executes on Channel Partner Strategy in Asia -06/11

Thwapr to Localize Its iPhone App for China -06/04

Thwapr Takes Steps to Protect Its Patent-Pending Technology in China -05/31

Thwapr, Inc. Provides Corporate Update on Asia Progress and Asian Outlook -05/29

_____

Omni Ventures, Inc. OMVE

Having seen higher lows for four consecutive sessions following a bounce off of its bottom, OMVE is another play that we dug up in our search for new blood.

Our penny-sense is starting to tingle, as all the chart indicators seem to be ripening up. We’ve generally observed, that once a stock moves past its 200DMA, a breakout often follows. That said, we’re looking at .22 (200DMA) as the next key area of resistance.

We’ve provided you with a video chart for OMVE as well:


____

We also wanted to congratulate anyone who was able to take advantage of our calls from yesterday’s report. Both YIPI and ARNA enjoyed solid performances during yesterday’s trading. Both stocks closed near their high-of-day on abnormally high volume.

____

Extended Watchlist:

RGIN, VPER,

YIPI, ARNA & Today’s Extended Watchlist

YIPI recently caught our attention, as a stock that has been on a steady incline for months now. Yesterday’s activity was exciting, and despite the Dow being down over 100 points, YIPI managed a nearly 60% gain.

Any stock that is doing this well during a relatively turbulent time is certainly worth a second look.

The company also had some news out yesterday:

Yippy, Inc. (YIPI) and MuseGlobal to Merge, Offering Unified Access to a Data Cloud of Curated Content

http://www.yippy.com

____

Arena Pharmaceuticals, Inc. ARNA

This stock has appeared on our newsletters before. On May 11th, we stated that “we want to watch this play carefully heading into the month of June, being the target month for FDA approval, as we believe that there could be trading opportunities in the meantime”

We turned out to be correct. In the days following our alert, the stock was trading as low as 5.50, and yesterday reached a high of 7.23, for a 31% gain. Should the company indeed receive the FDA approval it seeks, that 31% could be just a drop in bucket of some much larger gains.

We will keep our eyes peeled for any additional press coming over the wires. In the meantime here’s a link to this morning’s announcement:

Arena and VIVUS Race to Be the First in the Lucrative Anti-Obesity Drug Market

____
Extended Watchlist:

EEGC, CLNO

VPER, RARS & Today’s Extended Watchlist

VPER has been on our radars for quite some time, with our first alert coming on March 13th. Since that time, there’s been the opportunity to trade this stock for a handsome profit on 4-5 separate occasions.

Following the last run from .0016 to .0055, we’ve undegone a consoldidation, holding support in the low .002’s. Should the stock break past resistance at .0026, .0029, and .0031 (the 20, 100, & 50DMA ‘s respectively), there seems a strong chance that this play could return to .004’s and higher, and we certainly dont frown upon gains on the order of 50%

We have prepared a video chart for your convenience, which can be found below:


____

 

Rarus Technologies Inc. RARS

We have been silently monitoring RARS for weeks, although it has not yet appeared in our newsletter coverage. After witnessing last week’s activity, we felt compelled to share it with you today.

On Monday, the stock was trading as low as .071. By the time Wednesday rolled around, the high had touched .144, for a gain of 103%

That jump pushed the stock above its 20DMA, and providing it can hold at that level or above, we believe that the recovery off of its bottom could continue.

Rarus Technologies Inc. Announces Its Zngle Platform Will Create Revenues By Competing In a $39.5 Billion Market Through Development of Self-Serve Ad Platform PR Newswire – Mon 8:00AM

____

Extended Watchlist:

DOMK, MSLP, ICPA, MYOS, JNSH, RCHN,

ICPA, BMSN & Today’s Extended Watchlist

ICPA traded as low as .033 on Monday, only to hit .056 yesterday, for a 70% intraweek gain.

Our first alert of ICPA in 2012 came on January 19th. The stock hit its .0008 52-wk low the following day.

This weeks 70% gainer sure was nice, however, someone fortunate enough to wait patiently from its ultimate low to this weeks high wouild have seen gains on the order of 6900%

____

 

Bio-Matrix Scientific Group, Inc. BMSN

BMSN held nearly all of yesterday’s gains, closing at .0104, gaining 89%, and earning us the number one slot from our friends over at Penny Stock Rumble.

From the looks of the chart, all indicators suggest this wild runner is not yet ready to be saddled.

____
Extended Watchlist:
VPER, HOKU, MSLP, X

Get Our FREE Daily Reports!

SUBSCRIBE